Most #cancer cells arenβt able to propagate tumoursβbut a rare few can.
Using genetic barcodes, a team @pmresearch-uhn.bsky.social tracked these rare clonesβrevealing how they evolve, adapt, and resist treatment. A step toward more targeted cancer therapies.
π: www.uhnresearch.ca/news/rare-ca...
10.07.2025 17:59 β π 7 π 4 π¬ 1 π 0
Altogether, we illustrate the dynamic nature of transcriptional plasticity in propagating clones, highlighting their ability to evolve, adapt, and mature into dominant clones that constitute the majority of tumor cells in secondary xenografts, all originating from a single barcoded cell.
12.05.2025 13:18 β π 1 π 0 π¬ 0 π 0
Dominant propagating clones display dynamic transcriptional plasticity which we illustrate by profiling gene expression across generations of cells derived from single starting cells.
12.05.2025 13:18 β π 1 π 0 π¬ 1 π 0
Dichotomous cell populations in basal breast cancer distinguish between functional clone types based on differential signaling and metabolic responses. This suggests it is possible to enrich for cells with propagating activity.
12.05.2025 13:18 β π 1 π 0 π¬ 1 π 0
In vivo clone doubling time, a metric used to quantify the rate of clonal growth, reveals breast cancer subtype-specific differences in clonal fitness.
12.05.2025 13:18 β π 1 π 0 π¬ 1 π 0
We show that extremely rare cells can give rise to clones with propagating activity (frequency 1 in 15,000 β 1 in 116,000). Dominant propagating clones regenerate the full model-specific transcriptional landscape and there is a conserved differentiation program.
12.05.2025 13:18 β π 1 π 0 π¬ 1 π 0
In this paper we used expressed lentiviral barcoding to track the clonal growth of over 20,000 single-cell-derived clones in 110 xenografts from 26 patient-derived breast cancer xenograft models. We also profiled 167,375 single-cell RNA profiles to link clonal growth with gene expression.
12.05.2025 13:18 β π 2 π 0 π¬ 1 π 0
Redirecting
I am excited to share the latest publication from the Nguyen, Caldas @carloscaldas1960.bsky.social and Rueda labs @ruedalab.bsky.social. This was a massive effort from a fantastic team and Iβm grateful to everyone on the paper for their work on this project! doi.org/10.1016/j.ce...
#bcsm #PDTX
12.05.2025 13:18 β π 14 π 6 π¬ 3 π 9
Group Leader @MRC LMB. Passionate (neuro)immunology, the universe and every now and then some good old fashion fantasy π³οΈβπ (he/him). Opinions are my own.
https://www2.mrc-lmb.cam.ac.uk/group-leaders/n-to-s/noe-rodriguez/
https://orcid.org/0000-0001-7825-5634
Jack of some trades, master of none: public health, epi and genetics mainly. Arsenal supporter, hiker. Live in LA. If home is also where the heart is England, South Africa, Papua New Guinea. Photos are my own. Views expressed are my own.
Oncologist-scientist at Weill Cornell and New York genome center. Into somatic evolution, trees and words
Functional genomics of breast cancer lab based at the University of Cambridge
Enabling researchers to answer biologyβs hardest and most elusive questions with innovative #singlecell, #spatialbiology & #insitu technology.
Breast cancer functional genomics CRUK CI | Croucher scholar | MBChB (GPS), MSc CUHK | RET fusions MSKCC
Breast cancer physician scientist. Group Leader, ICR London. Consultant oncologist, the Royal Marsden Hospital. Advancing personalised breast cancer medicine through data integration and AI.
The ICR is making the discoveries that defeat cancer.
We're a top UK academic research centre, a postgrad college, and a charity.
π London (Chelsea and Sutton)
https://www.icr.ac.uk/
Peter MacCallum Cancer Centre β or Peter Mac β is a globally-connected leader in cancer treatment, care, research and education. Now in its 75th year of providing specialist cancer care for the Australian community.
Oncologist & Scientist @ Peter MacCallum Cancer Centre and The University of Melbourne
Head of Computational Biology at Fondazione Michelangelo, Milan, Italy. Cancer researcher and passionate photographer.
fondazionemichelangelo.org
Cancer programme Faculty @sangerinstitute.bsky.social & founder MosaicTx developing precision combination therapies. #Cancer, Functional genomics, biomarkers, target discovery, #organoid, #CRISPR. Proud π¨π¦.
The Netherlands Cancer Institute (NKI): at the international forefront of cancer research and treatment for over 100 years.
Publishing the latest advances across all areas of cancer research and oncology. Part of @natureportfolio.nature.com
π www.nature.com/natcancer/
πNew York, London, Berlin and Heidelberg
π¨π¬ Putting cancer in context π¬π¨
Systems breast cancer pathology Lab at @cruk-ci.bsky.social @cancerresearchuk.bsky.social @cambridge-uni.bsky.social
We fund cutting-edge scientific research across multiple Branches and Centers to better understand cancer and eliminate the suffering caused by the disease.
Welcome to the official Bluesky account for the New England Journal of Medicine!
Follow us for high-quality, peer-reviewed research and clinical content from the worldβs leading medical journal and website (NEJM.org).
https://www.camlab.ca | ML for cancer genomics + single-cell and spatial computational methods | Toronto Canada π₯οΈπ§¬